InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Nussbaum Ran, Director. Officer active across 2 companies, notably Eloxx Pharmaceuticals, Inc.. Cumulatively, 6 filings have been recorded. Total volume traded: €2.9m. The latest transaction was filed on 25 March 2021 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
€9,3582,211 shares@ €4.23260.0007% mcap68.2% of flow
Ordinary Shares
SEC:0001209191-21-039132·
€4,3601,030 shares@ €4.23260.0003% mcap31.8% of flow
Ordinary Shares
SEC:0001209191-21-039137·
€9,3582,211 shares@ €4.23260.0007% mcap34.1% of flow
Ordinary Shares
SEC:0001209191-21-039132:0·
€4,3601,030 shares@ €4.23260.0003% mcap15.9% of flow
Ordinary Shares
SEC:0001209191-21-039137:0·
€1m1,280,624 shares@ €1.1178100.0% of flow
Common Stock
SEC:0001104659-21-067335·
Ideal exit: 7 Feb 2022 (T+270)
€1m1,280,624 shares@ €1.117850.0% of flow
Common Stock
SEC:0001104659-21-067335:0·
Ideal exit: 7 Feb 2022 (T+270)
6 of 6 declarations
About Nussbaum Ran
Ran Nussbaum is a Board Member at Eloxx Pharmaceuticals, Inc. and UroGen Pharma Ltd. He is responsible for overseeing the operations and strategy of these companies. His experience in the pharmaceutical sector allows him to make significant contributions to strategic discussions. As a board member, he ensures that decisions made align with the growth and innovation objectives of the companies.
